AgelessRx vs Factor Health MD
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AgelessRx
Best for longevity-focused GLP-1 care (pending verification)Starting at $199/mo
Factor Health MD
Best for Cost-sensitive buyers seeking the broadest compounded GLP-1 selection (sema + tirz + liraglutide) at aggressive $99-$150/mo pricing with HSA/FSA payment acceptance and multi-product wellness platform consolidation. Particularly fit for patients seeking liraglutide specifically — rare in the DTC compounded market.Starting at $99/mo
Side-by-Side Comparison
| Feature | AgelessRx | Factor Health MD |
|---|---|---|
| Overall Score | ✓7.1/10 | 6.4/10 |
| Starting Price | $199/mo | ✓$99/mo |
| Editorial Rating | ✓3.6 ★ /5 | 3.2 ★ /5 |
| Features | 6 features | ✓13 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warnings | None | None |
Pros & Cons
AgelessRx
Pros
- ✓Established brand based in Ann Arbor, MI with US-licensed providers
- ✓Offers both compounded and brand-name (Wegovy) options
- ✓Longevity-first positioning — patients get a broader metabolic health framing vs single-condition GLP-1 funnels
- ✓Listed in both competitor directories
Cons
- ✗Stub entry — pricing, states served, and GLP-1-specific intake workflow need YMYL verification
- ✗Confidence LOW until verified
- ✗Longevity-first positioning means GLP-1 is one of several products — patients looking specifically for GLP-1 care may be funneled into a broader longevity intake
Factor Health MD
Pros
- ✓**3-GLP-1 lineup including liraglutide** — rare in the DTC market. Most platforms offer only semaglutide + tirzepatide. Liraglutide is older but still FDA-approved (as Saxenda for weight loss) and may suit patients sensitive to newer molecules or seeking shorter half-life.
- ✓Aggressive $99/mo starting tier with 'all doses included' framing — competitive entry pricing
- ✓Multi-product platform (GLP-1 + longevity + vitamin injectables + men's health + bundles)
- ✓HSA/FSA accepted (uncommon in DTC compounded GLP-1 market)
- ✓St Petersburg FL location anchor + phone (305-930-8817) for accountability
- ✓LegitScript verification badge displayed
- ✓Free medical consultations framing
- ✓'We don't increase the price per dose' = no per-tier price escalation as patients titrate up
Cons
- ✗Specific 503A/503B pharmacy partner NOT named
- ✗LegitScript ID NUMBER not visible in text (only badge displayed)
- ✗Full states-served list NOT disclosed publicly
- ✗Named medical director NOT disclosed
- ✗Verbatim FDA compounded-medication disclaimer text NOT prominently displayed
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed (footer copyright shows '2025' year)
- ✗Governing law / arbitration venue NOT disclosed
- ✗Compounded liraglutide has weaker evidence base for weight loss vs sema/tirz (older molecule, lower-magnitude TBWL in trials)
- ✗Tirzepatide pricing tier ($149/mo) less explicit than the $99 starting price advertised most prominently
Our Verdict
AgelessRx edges out Factor Health MD with a higher overall score of 7.1/10 and is particularly strong for longevity-focused GLP-1 care (pending verification). Factor Health MD remains a solid alternative, especially if you're looking for Cost-sensitive buyers seeking the broadest compounded GLP-1 selection (sema + tirz + liraglutide) at aggressive $99-$150/mo pricing with HSA/FSA payment acceptance and multi-product wellness platform consolidation. Particularly fit for patients seeking liraglutide specifically — rare in the DTC compounded market..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.